Emergence of resistance to erythromycin and fluoroquinolones in thermotolerant Campylobacter strains isolated from feces 1987-1991

Eur J Clin Microbiol Infect Dis. 1992 Dec;11(12):1163-6. doi: 10.1007/BF01961137.

Abstract

During the period 1987 to 1991 a retrospective study was performed to determine the resistance of thermotolerant Campylobacter species isolated from feces to erythromycin and fluoroquinolones. Of the 672 strains studied, 614 (91.3%) were identified as Campylobacter jejuni and 58 (8.7%) as Campylobacter coli. During the study period the rate of resistance of Campylobacter jejuni to erythromycin remained relatively stable (0.9-3.5%), while resistance of Campylobacter coli to erythromycin emerged later (1989) with much higher rates (14.8-33%). Overall, 11.8% and 10.7% of Campylobacter jejuni strains isolated after 1987 were resistant to nalidixic acid and ciprofloxacin respectively, resistance increasing from 2.3% in 1988 to 32% in 1991. In 1991 the first strains of Campylobacter coli with resistance to these fluoroquinolones were detected (rates 29% and 26% respectively). Of the strains resistant to nalidixic acid, only 10.9% were susceptible to ciprofloxacin.

MeSH terms

  • Anti-Infective Agents / therapeutic use*
  • Campylobacter / drug effects*
  • Campylobacter Infections / drug therapy*
  • Campylobacter coli / drug effects
  • Campylobacter coli / isolation & purification
  • Campylobacter jejuni / drug effects
  • Campylobacter jejuni / isolation & purification
  • Child
  • Drug Resistance, Microbial
  • Erythromycin / therapeutic use*
  • Feces / microbiology*
  • Fluoroquinolones
  • Hot Temperature
  • Humans
  • Retrospective Studies

Substances

  • Anti-Infective Agents
  • Fluoroquinolones
  • Erythromycin